Omeros Ownership
| 3O8 Stock | EUR 7.18 0.09 1.24% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Omeros |
Omeros Stock Ownership Analysis
About 33.0% of the company shares are owned by institutions such as pension funds. The company recorded a loss per share of 2.63. Omeros had not issued any dividends in recent years. Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system , and immune-related diseases. The company was incorporated in 1994 and is based in Seattle, Washington. OMEROS CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 236 people. For more info on Omeros please contact the company at 206 676 5000 or go to https://www.omeros.com.Omeros Outstanding Bonds
Omeros issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Omeros uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Omeros bonds can be classified according to their maturity, which is the date when Omeros has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| ON SEMICONDUCTOR P Corp BondUS682189AQ81 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Omeros Stock
When determining whether Omeros is a strong investment it is important to analyze Omeros' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Omeros' future performance. For an informed investment choice regarding Omeros Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Omeros Stock please use our How to Invest in Omeros guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.